MRI developer Advanced NMR and imaging services firm Medical Diagnosticscompleted their merger late last month after shareholders fromboth companies approved the deal (SCAN 5/10/95). MDI, of Burlington,MA, will become a subsidiary of Advanced NMR, which
MRI developer Advanced NMR and imaging services firm Medical Diagnosticscompleted their merger late last month after shareholders fromboth companies approved the deal (SCAN 5/10/95). MDI, of Burlington,MA, will become a subsidiary of Advanced NMR, which is based inWilmington, MA. John Lynch will continue as president and CEOof MDI and has been named senior vice president of Advanced NMR.Lynch and two other former MDI directors have been added to AdvancedNMR's board.
Study Shows No Impact of Hormone Therapy on PET/CT with 18F-Piflufolastat in PCa Imaging
May 7th 2025For patients with recurrent or metastatic prostate cancer, new research findings showed no significant difference in the sensitivity of 18F-piflufolastat PET/CT between patients on concurrent hormone therapy and those without hormone therapy.